BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31780139)

  • 1. Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy.
    Williams WH; Cata JP; Lasala JD; Navai N; Feng L; Gottumukkala V
    Br J Anaesth; 2020 Feb; 124(2):164-172. PubMed ID: 31780139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial.
    Paech MJ; Kaye R; Baber C; Nathan EA
    Anaesthesia; 2018 Mar; 73(3):340-347. PubMed ID: 29214645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine.
    Boggett S; Chahal R; Griffiths J; Lin J; Wang D; Williams Z; Riedel B; Bowyer A; Royse A; Royse C
    Anaesthesia; 2020 Sep; 75(9):1153-1163. PubMed ID: 32395901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
    Broens SJL; Boon M; Martini CH; Niesters M; van Velzen M; Aarts LPHJ; Dahan A
    Anesthesiology; 2019 Sep; 131(3):467-476. PubMed ID: 31045894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation.
    Deana C; Barbariol F; D'Incà S; Pompei L; Rocca GD
    BMC Anesthesiol; 2020 Mar; 20(1):70. PubMed ID: 32213163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: a prospective, randomised, double-blind trial in high-risk older patients.
    Ledowski T; Szabó-Maák Z; Loh PS; Turlach BA; Yang HS; de Boer HD; Asztalos L; Shariffuddin II; Chan L; Fülesdi B
    Br J Anaesth; 2021 Aug; 127(2):316-323. PubMed ID: 34127252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study.
    Abdulatif M; Lotfy M; Mousa M; Afifi MH; Yassen K
    Minerva Anestesiol; 2018 Aug; 84(8):929-937. PubMed ID: 29405667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
    Insinga RP; Joyal C; Goyette A; Galarneau A
    BMC Anesthesiol; 2016 Nov; 16(1):114. PubMed ID: 27852231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study.
    Min BH; Oh TK; Song IA; Jeon YT
    BMC Anesthesiol; 2020 Jul; 20(1):178. PubMed ID: 32693776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial.
    Wang X; Li Y; Huang C; Xiong W; Zhou Q; Niu L; Xiao Y
    BMJ Open; 2021 Feb; 11(2):e043935. PubMed ID: 33637547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of sugammadex reversal of neuromuscular block and postoperative length of stay in the ambulatory care facility: a multicentre hospital registry study.
    Azimaraghi O; Ahrens E; Wongtangman K; Witt AS; Rupp S; Suleiman A; Tartler TM; Wachtendorf LJ; Fassbender P; Choice C; Houle TT; Eikermann M; Schaefer MS
    Br J Anaesth; 2023 Mar; 130(3):296-304. PubMed ID: 36535827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery.
    Oh TK; Ryu JH; Nam S; Oh AY
    BMC Anesthesiol; 2020 Feb; 20(1):41. PubMed ID: 32079528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.